Deep Track Capital »

Amgen shares owned by Deep Track Capital

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $156M 550k 284.32

More positions owned by Deep Track Capital

Springworks Therapeutics (SWTX)
Amgen (AMGN)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Dyne Therapeutics (DYN)
Alnylam Pharmaceuticals (ALNY)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Intra Cellular Therapies Put Option (ITCI)
Intellia Therapeutics (NTLA)
Ocular Therapeutix (OCUL)
Dynavax Technologies Corp Com New (DVAX)
Axsome Therapeutics (AXSM)
Geron Corporation (GERN)
Autolus Therapeutics Spon Ads (AUTL)

View all positions for Deep Track Capital

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
PRIMECAP Management Company
Morgan Stanley
Geode Capital Management
Charles Schwab Investment Management
Wells Fargo & Company
Capital Research and Management Company - Division 3
Northern Trust
Capital Research Global Investors
Royal Bank of Canada
Bank of New York Mellon
Barclays
Legal & General Group

View all funds holding Amgen